Mr. Bradford C. Barton, also known as Brad, has been the Chief Operating Officer at Alliqua, Inc. since August 29, 2014. Mr. Barton served as the President of U.S. Business/ConvaTec Americas at ConvaTec Healthcare B S.a.r.l. He was responsible for all ConvaTec businesses in the U.S., Canada and Latin America. In his time at ConvaTec, he led the team responsible for the acquisition and integration of 180 Medical and Abviser. He was instrumental in helping to establish Convatec as a standalone company in the Americas. Prior to his America's role, he had responsibilities for ConvaTec's business in China, Asia, Japan and Australia. He joined ConvaTec in 1996. He has extensive knowledge of U.S. distribution channels, GPO's and the post acute care market segment. Mr. Barton has held a number of sales leadership roles at Calgon Corp. and Vestal Laboratories. He was responsible for the U.S. marketing and sales strategy of the Ostomy Care, Wound Therapeutics and Continence and Critical Care business units. Mr. Barton has more than 28 years of experience in sales and marketing, holding several positions throughout the company. He served as Vice President of Americas where he was responsible for driving revenue growth for Wound Therapeutics in U.S., Canada and Puerto Rico. In his tenure, he delivered positive results through the strategic alignment of the U.S. Wound Therapeutics sales force, the successful sales of growth products such as AQUACEL??? Ag SURGICAL and the retention and rebuilding of the Flexi-Seal??? FMS market share. He has also served in many different marketing and distribution roles throughout the company. Mr. Barton holds a Master of Business Administration degree from University of Phoenix and earned a Bachelor of Science in Biology from University of North Carolina.